US equities |
INTC $119.13 ▼-0.17% MU $1,074.89 ▲+0.00% NVDA $233.95 ▲+0.00% SNDK $1,719.99 ▲+0.00% SPCX $158.96 ▲+0.00% SDEV $7.48 ▲+0.00% TSLA $370.59 ▲+0.00% AMD $633.91 ▲+0.00%
FinancialContent

PerkinElmer (NY:PKI)

N/A UNCHANGED
Last Price Updated: 7:00 PM EDT, May 15, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about PerkinElmer

< Previous 1 2 3 4 5 6 Next >
Benzinga's Top Ratings Upgrades, Downgrades For November 28, 2022 ↗
 
Via Benzinga
News headline image
PerkinElmer Helps Accelerate Gene Therapy Research with Industry-First Ready-to-Use Viral Vector Assays
From PerkinElmer, Inc.
Via Business Wire
News headline image
PerkinElmer Announces its EONIS SCID-SMA Kit is First to Receive Marketing Authorization by U.S. FDA for SMA Screening in Newborns
From PerkinElmer Inc.
Via Business Wire
News headline image
PerkinElmer Clocks Lower Quarterly Earnings, But Beat Expectations ↗
 
Via Benzinga
News headline image
PerkinElmer to Present at 2022 Stifel Healthcare Conference
From PerkinElmer Inc.
Via Business Wire
News headline image
PerkinElmer Announces Financial Results for the Third Quarter of 2022
From PerkinElmer, Inc.
Via Business Wire
News headline image
PerkinElmer Bolsters Sustainability Commitments and Builds Off Recent Progress in New ESG Report
From PerkinElmer Inc.
Via Business Wire
News headline image
Analyst Ratings for PerkinElmer ↗
PerkinElmer (NYSE:PKI) has observed the following analyst ratings within the last quarter: 
Via Benzinga
News headline image
Analyst Ratings for PerkinElmer ↗
Analysts have provided the following ratings for PerkinElmer (NYSE:PKI) within the last quarter: 
Via Benzinga
News headline image
Expert Ratings for PerkinElmer ↗
Analysts have provided the following ratings for PerkinElmer (NYSE:PKI) within the last quarter: 
Via Benzinga
News headline image
PerkinElmer Board Declares Quarterly Dividend
From PerkinElmer, Inc.
Via Business Wire
News headline image
PerkinElmer Sweetens Its Outlook And Shares Surge, But There's Still One Hitch ↗
The company now expects several parameters to come in above initial forecasts. 
Via Investor's Business Daily
News headline image
PerkinElmer to Hold Earnings Call on Tuesday, November 8, 2022; Updates Third Quarter Outlook
From PerkinElmer, Inc.
Via Business Wire
News headline image
PerkinElmer Donation Helps Significantly Expand Capacity for Sickle Cell Disease Screening in Ghana
From PerkinElmer Inc.
Via Business Wire
News headline image
FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests ↗
 
Via Benzinga
News headline image
PerkinElmer Unveils Industry-first Cell Analysis Solution to Streamline Cell and Gene Therapy Research and Manufacturing
From PerkinElmer, Inc.
Via Business Wire
News headline image
COVID-19 Complacency Pushes Identification Of New Variants To Back Seat, WHO Warns ↗
The World Health Organization (WHO) warned that it struggles to identify and 
Via Benzinga
News headline image
PerkinElmer’s Oxford Immunotec Receives U.S. FDA Approval for T-Cell Select to Automate Clinically Superior Tuberculosis Detection
From PerkinElmer
Via Business Wire
News headline image
No More Free COVID-19 At-Home Tests, Federal Government Says ↗
CNBC reported that the federal government is set to suspend its offer of free at-home COVID-19 tests by Friday, September 2, without congressional au 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Wednesday ↗
  On Wednesday, 297 companies achieved new lows for the year. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022 ↗
Upgrades 
Via Benzinga
News headline image
PerkinElmer to Present at Upcoming Investor Conferences
From PerkinElmer Inc.
Via Business Wire
News headline image
What 7 Analyst Ratings Have To Say About PerkinElmer ↗
  Analysts have provided the following ratings for PerkinElmer (NYSE:PKI) within the last quarter: 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 18, 2022 ↗
  
Via Benzinga
News headline image
Former PerkinElmer Executive Joins Moderna As Finance Chief ↗
 
Via Benzinga
News headline image
PerkinElmer Announces Finance Leadership Transition
From PerkinElmer, Inc.
Via Business Wire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Pearson, Nikola And Some Other Big Gainers From Monday ↗
U.S. stocks closed slightly lower on Monday, with the Nasdaq Composite dropping around 02%. Here is the list of some big stocks moving higher in the previous session. 
Via Benzinga
News headline image
Why Revlon Shares Jumped 90%; Here Are 83 Biggest Movers From Yesterday ↗
Gainers Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPB) shares jumped 187.3% to close at $48.03 on Monday after gaining around 18% on Friday. 
Via Benzinga
News headline image
This Biotechnology Stock Is Trading Lower By 77%, Here Are 62 Stocks Moving In Monday's Mid-Day Session ↗
Gainers Ontrak, Inc. (NASDAQ: OTRK) gained 102% to $1.3150. Ontrak is expected to report financial results for the second quarter on Tuesday, August 9, 2022. 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >